Dear HIFA colleagues,
Regarding Q2, I have identified three categories of questions that women may have at different stages along the screening and treatment continuum.
1. Questions that influence the decision to get screened
Why should I get screened for cervical cancer?
Should I get screened even if I have already received the HPV vaccine?
How much does cervical cancer screening cost?
Where can I get screened near my home?
2. Questions from women who have decided to get screened
What should I expect during the screening process?
Will the screening procedure be painful?
What do the screening results mean?
3. Questions from women who test positive
Does a positive screening result mean that I have cervical cancer?
What treatment options are available?
Can I still have children after treatment?
I would also like to share a useful slide from the Alliance for Cervical Cancer Prevention (ACCP) that addresses women’s frequently asked questions about cervical cancer screening.
Women’s Frequently Asked Questions About Cervical Cancer Screening – PowerPoint presentation
https://www.slideserve.com/heinz/women-s-frequently-asked-questions-abou...
I would like to learn more about the diverse questions and concerns that women commonly have before, during, and after cervical cancer screening. What questions do women most frequently ask, and are there important concerns or information needs that are often overlooked?
Kind regards,
Emily
HIFA profile: Emily Suzuki is a medical doctor and attorney currently serving as a Technical Officer at the World Health Organization. She provides country-level support for cervical cancer elimination, with a focus on scaling up screening and treatment programmes. Her work includes technical assistance on programme design, procurement, and implementation across diverse health system settings. Before joining WHO, she worked at Japan’s Ministry of Health, Labour and Welfare, where she led litigation related to vaccination and contributed to evidence-based immunization policies. She is highly motivated to advance public health through effective health policy and programme implementation. She is a member of the HIFA working group on cervical cancer. https://www.hifa.org/support/members/emily-0 esuzuki AT who.int